Find where to buy products from suppliers in the USA, including: distributors, industrial manufacturers in America, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the American suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the UK.
| Product | Description | |
|---|---|---|
| Cholecystokinin | Cholecystokinin is a peptide hormone. Cholecystokinin, as a hunger suppressant, inhibits food intake and stimulates the digestion of fat and protein. Cholecystokinin can be used for the research of gastrointestinal system [1] [2] [3]. Uses: Scientific research. Group: Peptides. Alternative Names: Cholecystokinin-33(human); CCK-33(human). CAS No. 9011-97-6. Pack Sizes: 5 mg; 10 mg. Product ID: HY-P2932. |  |
| Cholecystokinin (26-33) (free acid) | Cholecystokinin (26-33) (CCK (26-33)) free acid is a cholecystokinin (CCK) fragment. Cholecystokinin (26-33) free acid can reduce food intake and gallbladder contraction [1]. Uses: Scientific research. Group: Peptides. Alternative Names: CCK (26-33) (free acid). CAS No. 103974-46-5. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P3651. | |
| Cholecystokinin-33 (human) | Cholecystokinin-33 (human) is a peptide hormone, holding great significance in biomedical research as it enables exploration into the intricacies of cholecystokinin receptors. Synonyms: CCK-39 (7-39) (human); H-Lys-Ala-Pro-Ser-Gly-Arg-Met-Ser-Ile-Val-Lys-Asn-Leu-Gln-Asn-Leu-Asp-Pro-Ser-His-Arg-Ile-Ser-Asp-Arg-Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2; L-lysyl-L-alanyl-L-prolyl-L-seryl-glycyl-L-arginyl-L-methionyl-L-seryl-L-isoleucyl-L-valyl-L-lysyl-L-asparagyl-L-leucyl-L-glutaminyl-L-asparagyl-L-leucyl-L-alpha-aspartyl-L-prolyl-L-seryl-L-histidyl-L-arginyl-L-isoleucyl-L-seryl-L-alpha-aspartyl-L-arginyl-L-alpha-aspartyl-O4-sulfo-L-tyrosyl-L-methionyl-glycyl-L-tryptophyl-L-methionyl-L-alpha-aspartyl-L-phenylalaninamide. Grades: ≥90%. CAS No. 96827-04-2. Molecular formula: C167H263N51O52S4. Mole weight: 3945.44. |  |
| Cholecystokinin (CCK) Fragment 26-33 Amide, Non-sulfated | ?95% (HPLC), powder. Group: Fluorescence/luminescence spectroscopy. |  |
| Cholecystokinin Fragment 30-33 Amide | ?95% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| Cholecystokinin Precursor (24-32) (rat) | Cholecystokinin Precursor (24-32) (rat) is a cholecystokinin precursor that can be expressed in the heart, lungs, and kidneys as well as in the gastrointestinal tract and brain. Cholecystokinin is a brain-gut peptide that stimulates gallbladder contraction and pancreatic exocrine secretion and also acts as a neurotransmitter [1]. Uses: Scientific research. Group: Peptides. Alternative Names: Prepro CCK Fragment V-9-M. CAS No. 99291-20-0. Pack Sizes: 5 mg; 10 mg. Product ID: HY-P2636. | |
| Cholecystokinin Precursor Fragment 107-115 Desulfated human | >97% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Cholecystokinin (26-33) (CCK-8) antibody produced in rabbit | whole antiserum. Group: Fluorescence/luminescence spectroscopy. | |
| (Tyr[SO3H]27)Cholecystokinin fragment 26-33 Amide | ?97% (HPLC), powder. Group: Fluorescence/luminescence spectroscopy. | |
| 1,4-Dithio-DL-threitol | Reagent for the quantitative reduction of disulfide group. Prevents the oxidation of cholecystokinin during its extraction from brain and duodenal tissues. Cleavage of disulfide bonds in proteins. Uses: Used as a reagent in biochemistry to prevent oxidation of thiol groups and to reduce disulfides to dithiols; has been used as a radioprotectant; dithiothreitol (dtt) is the common name for a small-molecule redox reagent known as cleland's reagent. Synonyms: DL-1,4-Dithiothreitol; DTT; Cleland's reagent; threo-1,4-Dimercapto-2,3-butanediol; Dithiothreitol; dl-Dithiothreitol; 1,4-Dithiothreitol; D-Dtt; 1,4-Dithio-dl-threitol; DL-Dithiothreitol; threo-1,4-Dimercapto-2,3-butanediol. Grades: ≥ 99 % (Assay by titration). CAS No. 3483-12-3. Molecular formula: C4H10O2S2. Mole weight: 154.25. | |
| [2-[[3-(2-Chlorobenzoyl)-5-ethyl-2-thienyl]amino]-2-oxoethyl]carbamic Acid Benzyl Ester | Used in the preparation of Clotiazepam (C587410) and thienylamide derivatives as cholecystokinin inhibitors. Group: Biochemicals. Alternative Names: [2-[[3-(2-Chlorobenzoyl)-5-ethyl-2-thienyl]amino]-2-oxoethyl]carbamic Acid Phenylmethyl Ester. Grades: Highly Purified. CAS No. 50508-73-1. Pack Sizes: 100mg. US Biological Life Sciences. |  Worldwide |
| 2-Amino-3-(2-chlorobenzoyl)-5-ethylthiophene | Used in the preparation of thienylamide derivatives as cholecystokinin inhibitors. Group: Biochemicals. Alternative Names: 2-Amino-3-(o-chlorobenzoyl)-5-ethylthiophene; 2-Amino-5-ethyl-3- (2-chlorobenzoyl) thiophene; (2-Amino-5-ethyl-3-thienyl)(2-chlorophenyl)-methanone. Grades: Highly Purified. CAS No. 50508-60-6. Pack Sizes: 250mg. US Biological Life Sciences. | Worldwide |
| (2S,4R)-Methyl-4-hydroxypiperidine-2-carboxylate | (2S,4R)-Methyl-4-hydroxypiperidine-2-carboxylate has been used as a reactant for the preparation of cholecystokinin B (CCK-B) antagonists. Group: Biochemicals. Grades: Highly Purified. CAS No. 211058-80-9. Pack Sizes: 10mg, 100mg. Molecular Formula: C7H13NO3, Molecular Weight: 159.18. US Biological Life Sciences. | Worldwide |
| Acetyl-asp-tyr[so3h]-met-gly-trp-met-nh2 | Acetyl-asp-tyr[so3h]-met-gly-trp-met-nh2. Uses: Designed for use in research and industrial production. Additional or Alternative Names: Acetyl-[Tyr(SO3H)27]-Cholecystokinin fragment 26-31 Amide, AC1N5SK8, C2795_SIGMA, 3-acetamido-4-[[1-[[1-[[2-[[1-[(1-amino-4-methylsulfanyl-1-oxobutan-2-yl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-1-oxo-3-(4-sulfooxyphenyl)propan-2-yl]amino]-4-oxobutanoic acid, 89911-65-9. Product Category: Heterocyclic Organic Compound. CAS No. 89911-65-9. Molecular formula: C38H50N8O13S3. Mole weight: 923.04. Purity: 0.96. IUPACName: 3-acetamido-4-[[1-[[1-[[2-[[1-[(1-amino-4-methylsulfanyl-1-oxobutan-2-yl)amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-1-oxo-3-(4-sulfooxyphenyl)propan-2-yl]amino]-4-oxobutanoic acid. Canonical SMILES: CC(=O)NC(CC(=O)O)C(=O)NC(CC1=CC=C(C=C1)OS(=O)(=O)O)C(=O)NC(CCSC)C(=O)NCC(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)NC(CCSC)C(=O)N. Product ID: ACM89911659. Alfa Chemistry ISO 9001:2015 Certified. Categories: CCK (26-31) (sulfated). |  |
| Asperlicin | Asperlicin is a non-peptide cholecystokinin (Cholecystokinin, CCK) produced by Aspergillus alliaceus. It has the effect of antagonizing CCK. A and its derivatives are promising for the treatment of ulcers and pancreatic tumors. Synonyms: Asperlicin A. CAS No. 93413-04-8. Molecular formula: C31H29N5O4. Mole weight: 535.59. | |
| CCK (26-30) (sulfated) | Cholecystokinin (CCK) is a neuropeptide and gut hormone that regulates pancreatic enzyme secretion and gastrointestinal motility, and acts as a satiety signal. CCK (26-30) is an N-terminal fragment of CCK, the sulfated form of CCK (26-30) inhibits binding of [125I]CCK-33 to guinea pig cortical membranes by 10% at 0.1 mM. Synonyms: N-Acetyl cholecystokinin (26-30) (sulfated). Grades: ≥95%. CAS No. 89911-69-3. Molecular formula: C33H41N7O12S2. Mole weight: 791.85. | |
| CCK (26-31) (sulfated) | Cholecystokinin (CCK) is a neuropeptide and gut hormone that regulates pancreatic enzyme secretion and gastrointestinal motility, and acts as a satiety signal. CCK (26-31) is an N-terminal fragment of CCK, the sulfated form of CCK (26-31) inhibits binding of [125I]CCK-33 to guinea pig cortical membranes by 21% at 0.1 mM. Synonyms: N-Acetyl cholecystokinin (26-31) (sulfated). Grades: ≥95%. CAS No. 89911-65-9. Molecular formula: C38H50N8O13S3. Mole weight: 923.05. | |
| CCK (27-33) (non-sulfated) | Cholecystokinin (CCK) is a neuropeptide and gut hormone that regulates pancreatic enzyme secretion and gastrointestinal motility, and acts as a satiety signal. CCK (27-33) is a C-terminal fragment of CCK. Non-sulfated CCK (27-33) inhibits binding of [3H]naloxone in rat cerebellum membranes with IC50 of 4 μM and inhibits electrically-stimulated contraction of isolated guinea pig ileum with IC50 of 17 μM. Synonyms: Cholecystokinin (27-33) (non-sulfated). Grades: ≥95%. CAS No. 47910-79-2. Molecular formula: C45H57N9O10S2. Mole weight: 948.12. | |
| CCK-4 Acetate | Tetragastrin is a tetrapeptide. Synonyms: CCK-4; CCK4; CCK 4; Gastrin Tetrapeptide; Cholecystokinin Octapeptide (5-8); Cholecystokinin Tetrapeptide; Gastrin (14-17) (human). CAS No. 35144-91-3. Molecular formula: C29H36N6O6S. Mole weight: 596.70. | |
| CCK Octapeptide (non-sulfated) | Cholecystokinin (CCK) is a neuropeptide and gut hormone that regulates pancreatic enzyme secretion and gastrointestinal motility, and acts as a satiety signal. CCK Octapeptide (non-sulfated) is the non-sulfated form of the C-terminal octapeptide of CCK. Synonyms: CCK-8 (desulfated); Cholecystokinin (CCK) (26-33); 2-desulfo-cholecystokinin-8 (swine). Grades: 98%. CAS No. 25679-24-7. Molecular formula: C49H62N10O13S2. Mole weight: 1063. | |
| CE-326597 | CE-326597 is a selective type 1 cholecystokinin receptor (CCK1R)agonist. In Mar 2009, Phase-II for Obesity in World was discontinued. Uses: Obesity. Synonyms: CE-326597; CE326597; CE 326597. (S)-2-(4-((1H-indol-3-yl)methyl)-5-oxo-1-phenyl-4,5-dihydro-6H-benzo[b][1,2,4]triazolo[4,3-d][1,4]diazepin-6-yl)-N-benzyl-N-isopropylacetamide. Grades: 98%. CAS No. 870615-40-0. Molecular formula: C37-H34-N6-O2. Mole weight: 594.72. | |
| Ceruletide | Ceruletide is a decapeptide and a potent cholecystokinin receptor agonist. Ceruletide is a safe and effective cholecystokinetic agent with a direct spasmogenic effect on the gallbladder muscle and bile ducts [1]. Uses: Scientific research. Group: Peptides. Alternative Names: Caerulein; Cerulein; FI-6934. CAS No. 17650-98-5. Pack Sizes: 100 μg; 500 μg; 1 mg; 5 mg. Product ID: HY-A0190. | |
| Devazepide | Devazepide is a potent and orally active cholecystokinin A(CCK-A) receptor antagonist with IC50 value of 0.26 nM. It is a derivative of benzodiazepine that displays appetite-stimulant effects. It blocks the anorectic response to CCK-8 and increases food intake in rats. It increases appetite and accelerates gastric emptying. It is used as a potential treatment for a variety of gastrointestinal problems including gastroparesis, dyspepsia and gastric reflux. It was developed by Merck Sharp & Dohme and was terminated in clinic phase 2 trials. Uses: Devazepide is used as a potential treatment for a variety of gastrointestinal problems including gastroparesis, dyspepsia and gastric reflux. Synonyms: (3S)-1-Methyl-3-[(1H-indol-2-yl)carbonylamino]-5-phenyl-1H-1,4-benzodiazepin-2(3H)-one;L-364718;MK-329;(S)-N-(2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl)indole-2-carboxamide;MK-329;MK329;N-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-1H-indole-2-carboxamide. Grades: >99 %. CAS No. 103420-77-5. Molecular formula: C25H20N4O2. Mole weight: 408.45. | |
| Devazepide | Devazepide (L-364,718) is a potent, competitive, selective and orally active nonpeptide antagonist of cholecystokinin (CCK) receptor , with IC 50 s of 81 pM, 45 pM and 245 nM for rat pancreatic, bovine gallbladder and guinea pig brain CCK receptors, respectively. Devazepide (L-364,718) is effective for gastrointestinal disorders [1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: L-364,718; MK-329. CAS No. 103420-77-5. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-106301. | |
| Dexloxiglumide | Dexloxiglumide is a selective cholecystokinin type A (CCKA) receptor antagonist [1]. Dexloxiglumide, the active enantiomer of Loxiglumide, inhibits smooth muscle cell contractions induced by cholecystokinin-octapeptide (CCK-8) [2]. Uses: Scientific research. Group: Signaling pathways. CAS No. 119817-90-2. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-128878. | |
| Gastrin I, human | Gastrin I, human is the endogenous peptide produced in the stomach, and increases gastric acid secretion via cholecystokinin 2 (CCK2) receptor. Uses: Scientific research. Group: Peptides. CAS No. 10047-33-3. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P1097. | |
| H-Ile-lys-asn-leu-gln-ser-leu-asp-pro-ser-his-oh | H-Ile-lys-asn-leu-gln-ser-leu-asp-pro-ser-his-oh. Uses: Designed for use in research and industrial production. Additional or Alternative Names: CCK-33 (10-20) (BOVINE, PORCINE);CCK-39 (16-26) (BOVINE, PORCINE);CCK-58 (35-45) (BOVINE, PORCINE);CHOLECYSTOKININ-33 (10-20) (BOVINE, PORCINE);CHOLECYSTOKININ (10-20);ILE-LYS-ASN-LEU-GLN-SER-LEU-ASP-PRO-SER-HIS;IKNLQSLDPSH;H-ILE-LYS-ASN-LEU-GLN-SER-LEU-. Product Category: Heterocyclic Organic Compound. CAS No. 100900-23-0. Molecular formula: C54H90N16O18. Mole weight: 1251.39. Product ID: ACM100900230. Alfa Chemistry ISO 9001:2015 Certified. | |
| JNJ17156516 | JNJ17156516 is a potent, novel and selective cholecystokinin 1 receptor antagonist. It showed high-affinity at the cloned human and canine CCK1 receptors. It was also highly selective for the CCK1 receptor compared with the CCK2 receptor across the same species. Synonyms: JNJ-17156516; JNJ 17156516; JNJ17156516; (S)-3-(5-(3,4-Dichlorophenyl)-1-(4-methoxyphenyl)-1H-pyrazol-3-yl)-2-(3-methylphenyl)propionic acid. Grades: 98%. CAS No. 649551-06-4. Molecular formula: C26H22Cl2N2O3. Mole weight: 481.37. | |
| JNJ17156516 sodium | JNJ17156516 sodium is the sodium salt form of JNJ17156516, which is a potent, novel and selective cholecystokinin 1 receptor antagonist. It showed high-affinity at the cloned human and canine CCK1 receptors. It was also highly selective for the CCK1 receptor compared with the CCK2 receptor across the same species. Synonyms: JNJ-17156516 sodium; JNJ 17156516 sodium; JNJ17156516 sodium; 1H-Pyrazole-3-propanoic acid, 5-(3,4-dichlorophenyl)-1-(4-methoxyphenyl)-alpha-(3-methylphenyl)-, sodium salt (1:1), (alphaS)-;(S)-3-(5-(3,4-Dichlorophenyl)-1-(4-methoxyphenyl)-1H-pyrazol-3-yl)-2-(3-methylphenyl)propionic acid sodium s. Grades: 98%. CAS No. 648861-58-9. Molecular formula: C26H21Cl2N2NaO3. Mole weight: 503.35. | |
| L-365,260 | L-365,260 is a nonpeptide cholecystokinin receptor 2 (CCK2/CCKB) antagonist. It selectively binds to gastrin and CCK2 sites to reduce basal acid secretion, and prevent gastrointestinal damage in models of peptic ulcer disease. Synonyms: N-[(3R)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-N'-(3-methylphenyl)urea. Grades: ≥99% by HPLC. CAS No. 118101-09-0. Molecular formula: C24H22N4O2. Mole weight: 398.46. | |
| Lorglumide sodium | Lorglumide sodium is a potent and selective cholecystokinin A (CCKA) antagonist. CCKA is a peptide hormone of the gastrointestinal system that promotes fat and protein digestion. Lorglumide is used as a drug suppressing gastrointestinal motility and reducing gastric secretions. Synonyms: Lorglumide sodium salt; 4-[(3,4-dichlorobenzoyl)amino]-5-(dipentylamino)-5-oxopentanoate sodium. Grades: ≥98%. CAS No. 1021868-76-7. Molecular formula: C22H31Cl2N2O4·Na. Mole weight: 481.4. | |
| Loxiglumide | Loxiglumide is a cholecystokinin ( CCK-1 ) receptor antagonist. Uses: Scientific research. Group: Signaling pathways. Alternative Names: CR-1505. CAS No. 107097-80-3. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg. Product ID: HY-B2154. | |
| Loxiglumide | Loxiglumide is an orally active, potent and selective small-molecule antagonist of the cholecystokinin receptor CCKA. It stimulates calorie intake and hunger feelings in humans. It could antagonize the CCK-induced reduction of gastric emptying in rats, accelerate the intestinal transport and accelerate the gallbladder emptying in mice. It inhibits pancreatic secretion of digestive enzymes, and also blocks CCK-induced gastric secretions and emptying. Uses: Loxiglumide stimulates calorie intake and hunger feelings in humans. it inhibits pancreatic secretion of digestive enzymes. Synonyms: CR-1505; CR 1505; CR1505; D,L-4-(3,4-dichlorobenzoylamino)-5-(n-3-methoxypropylpentylamino)-5-oxo-pentanoicacid;Pentanoicacid,4-((3,4-dichlorobenzoyl)amino)-5-((3-methoxypropyl)pentylamino);CR-1505;CR1505;4-(3,4-Dichlorobenzamido)-5-((3-methoxypropyl)(pentyl)amino)-5-oxopentanoic acid. Grades: 95%. CAS No. 107097-80-3. Molecular formula: C21H30Cl2N2O5. Mole weight: 461.38. | |
| LY 225910 | LY 225910 is a selective antagonist for cholecystokinin receptor ( CCK2 receptor ), which affects the excitatory response to morphine, and leads to morphine sensitization [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 133040-77-4. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-101352. | |
| Native Porcine Pancreozymin | Cholecystokinin is a peptide hormone of the gastrointestinal system responsible for stimulating the digestion of fat and protein. Cholecystokinin, previously called pancreozymin, is synthesized by I-cells in the mucosal epithelium of the small intestine and secreted in the duodenum, the first segment of the small intestine, and causes the release of digestive enzymes and bile from the pancreas and gallbladder, respectively. It also acts as a hunger suppressant. Recent evidence has suggested that it also plays a major role in inducing drug tolerance to opioids like morphine and heroin, and is partly implicated in experiences of pain hypersensitivity during opioid withdrawal. Applications: Cholecystokinin (cck) is a peptide hormone of the gastrointestinal system responsible for stimulating the digestion of fat and protein. it is used to study brain, kidney and pancreatic functioning as well as reproductive behavior and glucose tolerance. Group: Enzymes. Synonyms: Cholecystokinin, CCK, CCK-PZ; 9011-97-6; Pancreozymin. CAS No. 9011-97-6. CCK. Activity: 2-6 Crick units/mg solid. Storage: 2-8°C. Source: Porcine intestine. Species: Porcine. Cholecystokinin, CCK, CCK-PZ; 9011-97-6; Pancreozymin. Cat No: NATE-0113. |  |
| Neuropeptide Y (porcine) | Neuropeptide Y (porcine) is a widely distributed endogenous neuropeptide involved in regulation of circadian rhythms, sexual functioning, anxiety and stress response, and regulation of food intake (Ki= 0.17, 0.04 nM at human and Y2 respectively). It inhibits cholecystokinin- and secretin-stimulated pancreatic secretion. Synonyms: H-Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2. CAS No. 83589-17-7. Molecular formula: C190H287N55O57. Mole weight: 4254. | |
| Pancreatic Polypeptide, bovine | Pancreatic Polypeptide, bovine, a straight chain polypeptide containing 36 amino acids, derived primarily from the pancreas, and stimulates pancreatic secretion by inhibiting secretin and cholecystokinin. As the NPY receptor agonist, it has a high affinity at NPYR4. Synonyms: Ala-Pro-Leu-Glu-Pro-Glu-Tyr-Pro-Gly-Asp-Asn-Ala-Thr-Pro-Glu-Gln-Met-Ala-Gln-Tyr-Ala-Ala-Glu-Leu-Arg-Arg-Tyr-Ile-Asn-Met-Leu-Thr-Arg-Pro-Arg-Tyr-NH2; Pancreatic polypeptide (pig), 6-L-glutamic acid-; Bovine pancreatic polypeptide. Grades: ≥95%. CAS No. 179986-89-1. Molecular formula: C186H287N53O56S2. Mole weight: 4225.78. | |
| PD 136450 | PD-136,450 is a Cholecystokinin type B receptor antagonist originated by Pfizer. It is a partial secretory agonist in the stomach and a full agonist in the pancreas of the rat. It has therapeutic potential as acid antisecretory drugs, and may be of use as adjuvant therapy for gastrin sensitive tumours. No development for the treatment of Peptic ulcer was reported. Uses: Peptic ulcer. Synonyms: Cam 1189; Cam-1189; Cam1189; PD-136450; PD136450; PD 136450;(E)-4-((2-(2-(((adamantan-2-yloxy)carbonyl)amino)-3-(1H-indol-3-yl)-2-methylpropanamido)-1-phenylethyl)amino)-4-oxobut-2-enoic acid. Grades: 98%. CAS No. 139067-52-0. Molecular formula: C35H40N4O6. Mole weight: 612.72. | |
| PD-140376 | PD-140376 has been found to be a cholecystokininB/gastrin receptor antagonist that could probably be useful in the study of sorts of gastrointestinal disorders. Synonyms: PD-140376; PD 140376; AC1L52KZ; 3-((4-Aminophenyl)methyl)-N-(alpha-methyl-N-((tricyclo(3.3.1.1)dec-2-yloxy)carbonyl)-D-tryptophyl)-beta-alanine; OR223333. Grades: 98%. CAS No. 149027-97-4. Molecular formula: C33H40N4O5. Mole weight: 572.71. | |
| Pentagastrin | Pentagastrin (ICI-50123) is a potent, selective Cholecystokinin B (CCK B ) receptor antagonists with IC 50 values of 11 nM and 1100 nM for CCK B and CCK A , respectively. Pentagastrin enhances gastric mucosal defense mechanisms against acid and protects the gastric mucosa from experimental injury [1]. [2]. Uses: Scientific research. Group: Peptides. Alternative Names: ICI-50123. CAS No. 5534-95-2. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-A0261. | |
| Pranazepide | Pranazepide (FR120480) is a cholecystokinin-A receptor antagonist [1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: FR120480. CAS No. 150408-73-4. Pack Sizes: 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-105257. | |
| Proglumide | Anticholinergic, cholecystokinin Receptor. Group: Biochemicals. Alternative Names: 4-(Benzoylamino)-5-(dipropylamino)-5-oxo-pentanoic Acid; DL-4-Benzamido-N,N-dipropylglutaramic Acid; (+/-)-Proglumide; Binoside; CR 242; DL-4-Benzamido-N,N-dipropylglutaramic Acid; DL-Proglumide; Gastrotopic; Midelid; Milid; Milide; Nulsa; Promid; Ulcutin; W 5219; Xyde; Xylamide; Xylamide. Grades: Highly Purified. CAS No. 6620-60-6. Pack Sizes: 1g. US Biological Life Sciences. | Worldwide |
| Proglumide | Proglumide is a nonpeptide and orally active cholecystokinin (CCK)-A/B receptors antagonist. Proglumide selective blocks CCK s effects in the central nervous system (CNS). Proglumide has ability to inhibit gastric secretion and to protect the gastroduodenal mucosa. Proglumide also has antiepileptic and antioxidant activities [1] [2] [3] [4] [5]. Uses: Scientific research. Group: Signaling pathways. CAS No. 6620-60-6. Pack Sizes: 10 mM * 1 mL; 50 mg; 100 mg. Product ID: HY-B1330. | |
| Proglumide sodium | Proglumide sodium is a nonpeptide and orally active cholecystokinin (CCK)-A/B receptors antagonist. Proglumide sodium selective blocks CCK s effects in the central nervous system (CNS). Proglumide sodium has ability to inhibit gastric secretion and to protect the gastroduodenal mucosa. Proglumide sodium also has antiepileptic and antioxidant activities [1] [2] [3] [4] [5]. Uses: Scientific research. Group: Signaling pathways. CAS No. 99247-33-3. Pack Sizes: 10 mM * 1 mL; 50 mg; 100 mg. Product ID: HY-103354. | |
| Proglumide sodium salt | Proglumide sodium salt is a non-selective cholecystokinin (CCK) antagonist. Proglumide sodium salt is a non-peptide cholecystokinin receptor antagonist that has greater selectivity for the CCKA subtype. Synonyms: 4-(Benzoylamino)-5-(dipropylamino)-5-oxopentanoic acid sodium salt. Grades: ≥99% by HPLC. CAS No. 99247-33-3. Molecular formula: C18H25N2NaO4. Mole weight: 356.39. | |
| Sincalide | It is a synthetically-prepared C-terminal octapeptide of cholecystokinin.Sincalide (INN) is a cholecystokinetic drug administered by injection to aid in diagnosing disorders of the gallbladder and pancreas. It is the 8-amino acid C-terminal fragment of cholecystokinin. Synonyms: Sincalide. Grades: >98%. CAS No. 25126-32-3. Molecular formula: C49H62N10O16S3. Mole weight: 1143.29. | |
| Sincalide | Sincalide (Cholecystokinin octapeptide, CCK?8) is a rapid-acting amino acid polypeptide hormone analogue of cholecystokinin (CCK) for intravenous use in postevacuation cholecystography. CCK?8 is a major bioactive segment of CCK that retains most of the biological activities of CCK. CCK?8 can promote gallbladder contraction by injection and helps diagnose gallbladder and pancreas disorders. CCK?8 can increase bile secretion, cause the gallbladder to contract and relax the sphincter of Oddi, resulting in bile drainage into the duodenum. CCK?8 is a major bioactive segment of CCK that retains most of the biological activities of CCK [1] [2] [3]. Uses: Scientific research. Group: Peptides. Alternative Names: Cholecystokinin octapeptide; CCK-8; SQ19844. CAS No. 25126-32-3. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P0093. | |
| Sincalide ammonium | Sincalide ammonium (Cholecystokinin octapeptide ammonium, CCK-8 ammonium) is a rapid-acting amino acid polypeptide hormone analogue of cholecystokinin (CCK) for intravenous use in postevacuation cholecystography. Sincalide ammonium is a major bioactive segment of CCK that retains most of the biological activities of CCK. CCK?8 can promote gallbladder contraction by injection and helps diagnose gallbladder and pancreas disorders. Sincalide ammonium can increase bile secretion, cause the gallbladder to contract and relax the sphincter of Oddi, resulting in bile drainage into the duodenum. Sincalide ammonium is a major bioactive segment of CCK that retains most of the biological activities of CCK [1] [2] [3]. Uses: Scientific research. Group: Peptides. Alternative Names: Cholecystokinin octapeptide ammonium; CCK-8 ammonium; SQ19844 ammonium. CAS No. 70706-98-8. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P0093A. | |
| Tetragastrin | Tetragastrin is a potent releaser of insulin and other islet hormones. Synonyms: Gastrin tetrapeptide; Cholecystokinin tetrapeptide; CCK-4; (S)-4-(((S)-1-amino-1-oxo-3-phenylpropan-2-yl)amino)-3-((S)-2-((S)-2-amino-3-(1H-indol-3-yl)propanamido)-4-(methylthio)butanamido)-4-oxobutanoic acid. CAS No. 1947-37-1. Molecular formula: C29H36N6O6S. Mole weight: 596.71. | |
Our database is helping our users find suppliers everyday.
